FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Priority Review for Axsome Alzheimer's Agitation Drugs

[ Price : $8.95]

FDA grants priority review for an Axsome Therapeutics sNDA to treat Alzheimers disease agitation.

Hoeg, Prasad Draw Vaccine Concerns

[ Price : $8.95]

Two lengthy news service stories raise questions about FDAs approach to vaccines being espoused by CDER director Tracy Beth Heg an...

CRL for Sanofi Multiple Sclerosis Drug

[ Price : $8.95]

FDA issues a complete response letter to Sanofis NDA for tolebrutinib to treat non-relapsing secondary progressive multiple sclero...

FDA Cites Dr. Reddys Labs Over Inspection Findings

[ Price : $8.95]

An inspection of a Dr. Reddy's India manufacturing plant raises significant GMP issues in a new Form FDA 483.

Skinny Label Safe Harbor Bills Introduced

[ Price : $8.95]

Lawmakers introduce bipartisan legislation in the House and Senate to provide a skinny label safe harbor for certain human and ani...

Tower Laboratories CGMP Violations

[ Price : $8.95]

FDA warns Montague, MI-based Tower Laboratories about CGMP violations in its manufacture of finished drugs.

Repeat CGMP Violations Seen in LiquidCapsule Inspection

[ Price : $8.95]

FDA warns Tampa, FL-based LiquidCapsule Manufacturing about repeated CGMP violations in its production of finished drugs.

Two Digital Health Guidances Published

[ Price : $8.95]

FDA publishes digital health guidances relating to low-risk general wellness products and clinical decision support software.

Formal Dispute Resolution Guidance

[ Price : $8.95]

FDA posts a guidance on Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of...

End-of-December Warning Letters

[ Price : $8.95]

FDA releases substantive Warning Letters in the last two weeks of December 2025.